These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28654764)

  • 21. Does Systemic Sclerosis-associated Interstitial Lung Disease Burn Out? Specific Phenotypes of Disease Progression.
    Guler SA; Winstone TA; Murphy D; Hague C; Soon J; Sulaiman N; Li KH; Dunne J; Wilcox PG; Ryerson CJ
    Ann Am Thorac Soc; 2018 Dec; 15(12):1427-1433. PubMed ID: 30188737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
    Yamakawa H; Takemura T; Iwasawa T; Yamanaka Y; Ikeda S; Sekine A; Kitamura H; Baba T; Iso S; Okudela K; Kuwano K; Ogura T
    BMC Pulm Med; 2018 Jan; 18(1):25. PubMed ID: 29382307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of computer-based computer tomography stratification against outcome models in connective tissue disease-related interstitial lung disease: a patient outcome study.
    Jacob J; Bartholmai BJ; Rajagopalan S; Brun AL; Egashira R; Karwoski R; Kokosi M; Wells AU; Hansell DM
    BMC Med; 2016 Nov; 14(1):190. PubMed ID: 27876024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
    Meloni F; Caporali R; Marone Bianco A; Paschetto E; Morosini M; Fietta AM; Patrizio V; Bobbio-Pallavicini F; Pozzi E; Montecucco C
    Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):111-8. PubMed ID: 15281432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.
    Suliman YA; Dobrota R; Huscher D; Nguyen-Kim TD; Maurer B; Jordan S; Speich R; Frauenfelder T; Distler O
    Arthritis Rheumatol; 2015 Dec; 67(12):3256-61. PubMed ID: 26316389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
    Wells AU; Flaherty KR; Brown KK; Inoue Y; Devaraj A; Richeldi L; Moua T; Crestani B; Wuyts WA; Stowasser S; Quaresma M; Goeldner RG; Schlenker-Herceg R; Kolb M;
    Lancet Respir Med; 2020 May; 8(5):453-460. PubMed ID: 32145830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal assessment of interstitial lung disease in single lung transplant recipients with scleroderma.
    Hinze AM; Lin CT; Hussien AF; Perin J; Venado A; Golden JA; Boin F; Brown RH; Wise RA; Wigley FM
    Rheumatology (Oxford); 2020 Apr; 59(4):790-798. PubMed ID: 31504916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension.
    Antoniou KM; Margaritopoulos GA; Goh NS; Karagiannis K; Desai SR; Nicholson AG; Siafakas NM; Coghlan JG; Denton CP; Hansell DM; Wells AU
    Arthritis Rheumatol; 2016 Apr; 68(4):1004-12. PubMed ID: 26636545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Respiratory bronchiolitis-associated interstitial lung disease (RB-ILD)].
    Goeckenjan G
    Pneumologie; 2003 May; 57(5):278-87. PubMed ID: 12784181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Idiopathic inflammatory myositis-associated interstitial lung disease: ethnicity differences and lung function trends in a British cohort.
    Chua F; Higton AM; Colebatch AN; O'Reilly K; Grubnic S; Vlahos I; Edwards CJ; Kiely PD
    Rheumatology (Oxford); 2012 Oct; 51(10):1870-6. PubMed ID: 22763991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
    Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
    Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum B cell-activating factor (BAFF) level in connective tissue disease associated interstitial lung disease.
    Hamada T; Samukawa T; Kumamoto T; Hatanaka K; Tsukuya G; Yamamoto M; Machida K; Watanabe M; Mizuno K; Higashimoto I; Inoue Y; Inoue H
    BMC Pulm Med; 2015 Sep; 15():110. PubMed ID: 26424433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis.
    Kennedy B; Branagan P; Moloney F; Haroon M; O'Connell OJ; O'Connor TM; O'Regan K; Harney S; Henry MT
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep; 32(3):228-36. PubMed ID: 26422568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrocyte measurement in peripheral blood correlates with number of cultured mature fibrocytes in vitro and is a potential biomarker for interstitial lung disease in Rheumatoid Arthritis.
    Just SA; Lindegaard H; Hejbøl EK; Davidsen JR; Bjerring N; Hansen SWK; Schrøder HD; Hansen IMJ; Barington T; Nielsen C
    Respir Res; 2017 Jul; 18(1):141. PubMed ID: 28720095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
    Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
    Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiologic and pathologic characteristics of myeloperoxidase-antineutrophil cytoplasmic antibody-associated interstitial lung disease: a retrospective analysis.
    Baqir M; Yi EE; Colby TV; Cox CW; Ryu JH; Specks U
    Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(3):195-201. PubMed ID: 32476954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II.
    Goldin JG; Kim GHJ; Tseng CH; Volkmann E; Furst D; Clements P; Brown M; Roth M; Khanna D; Tashkin DP
    Ann Am Thorac Soc; 2018 Nov; 15(11):1286-1295. PubMed ID: 30265153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis.
    Fisher JH; Kolb M; Algamdi M; Morisset J; Johannson KA; Shapera S; Wilcox P; To T; Sadatsafavi M; Manganas H; Khalil N; Hambly N; Halayko AJ; Gershon AS; Fell CD; Cox G; Ryerson CJ
    BMC Pulm Med; 2019 Nov; 19(1):223. PubMed ID: 31771541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exertional hypoxemia is more severe in fibrotic interstitial lung disease than in COPD.
    Du Plessis JP; Fernandes S; Jamal R; Camp P; Johannson K; Schaeffer M; Wilcox PG; Guenette JA; Ryerson CJ
    Respirology; 2018 Apr; 23(4):392-398. PubMed ID: 29193512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease.
    Natalini JG; Swigris JJ; Morisset J; Elicker BM; Jones KD; Fischer A; Collard HR; Lee JS
    Respir Med; 2017 Jun; 127():1-6. PubMed ID: 28502413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.